New Prior Authorization Proposals: Implications for Prescription Drug Access Jeff ByersandMichael S. Gerber April 24, 2026

https://www.healthaffairs.org/do/10.1377/hp20260423.626376/full/?utm_campaign=podcast&utm_medium=email&_hsenc=p2ANqtz-8AKh9tc2c7lwiwd8YGwKSzg8GXMbeWtjGYlOhiGzv0nyFNyC0gwFgFB-2nil87YC81AIIHhdNKS6mDiz7W5HkXq-K1Ew&_hsmi=415566602&utm_content=hatw&utm_source=hasu Health Affairs Publishing's Jeff Byers welcomes Senior Editor Michael Gerber back to the pod to discuss recent federal action on prior authorization, including CMS’s proposal to expand response-time requirements to prescription drugs. The conversation also covers insurer efforts to reduce prior auth volume, the promise of AI and prior authorization, and what increased transparency could reveal about costs.